XJPX5592
Market cap103mUSD
Jan 17, Last price
1,470.00JPY
1D
-1.80%
1Q
11.53%
IPO
-22.43%
Name
Kusurinomadoguchi Inc
Chart & Performance
P/E
18.53
P/S
1.85
EPS
79.32
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
8.72b
+17.53%
Net income
871m
+122.49%
CFO
2.63b
-15.16%
Dividend
Mar 28, 20250 JPY/sh
Profile
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | |
| Income | |||
Revenues | 8,721,460 17.53% | 7,420,793 14.36% | 6,489,257 |
Cost of revenue | 3,788,605 | 6,370,771 | 5,774,229 |
Unusual Expense (Income) | |||
NOPBT | 4,932,855 | 1,050,022 | 715,028 |
NOPBT Margin | 56.56% | 14.15% | 11.02% |
Operating Taxes | 432,156 | 360,133 | 175,731 |
Tax Rate | 8.76% | 34.30% | 24.58% |
NOPAT | 4,500,699 | 689,889 | 539,297 |
Net income | 870,921 122.49% | 391,451 -24.08% | 515,609 |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | 2,815,200 | ||
BB yield | -19.56% | ||
| Debt | |||
Debt current | 5,100,000 | 100,000 | 112,072 |
Long-term debt | 313,624 | 27,663 | 37,491 |
Deferred revenue | |||
Other long-term liabilities | 381,946 | 275,443 | 223,670 |
Net debt | (9,302,513) | (5,990,729) | (5,225,245) |
| Cash flow | |||
Cash from operating activities | 2,627,199 | 3,096,744 | 3,655,799 |
CAPEX | (18,000) | (1,525,995) | (1,076,169) |
Cash from investing activities | (1,794,569) | (1,537,495) | (541,101) |
Cash from financing activities | 7,811,667 | (635,391) | (564,829) |
FCF | 4,028,287 | 1,192,673 | |
| Balance | |||
Cash | 14,590,947 | 5,946,649 | 5,022,791 |
Long term investments | 125,190 | 171,743 | 352,017 |
Excess cash | 14,280,064 | 5,747,352 | 5,050,345 |
Stockholders' equity | 3,372,708 | 1,153,579 | 1,166,718 |
Invested Capital | 8,841,290 | 1,884,395 | 2,155,667 |
ROIC | 83.92% | 34.15% | 25.02% |
ROCE | 40.39% | 34.56% | 21.52% |
| EV | |||
Common stock shares outstanding | 10,368 | 9,181 | 10,880 |
Price | 1,388.00 | ||
Market cap | 14,390,509 | ||
EV | 5,138,433 | ||
EBITDA | 5,966,362 | 1,883,426 | 1,391,468 |
EV/EBITDA | 0.86 | ||
Interest | 8,389 | 9,680 | 32,819 |
Interest/NOPBT | 0.17% | 0.92% | 4.59% |